Tesla recalling nearly 16,000 of its 2021

FILE-TheTeslacompanylogoisshownataTesladealershipinLittleton,Colo.Feb.2,2020.Teslasaidinitssafetyrec 3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou




comprehensive

author：focus    Page View：576

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

advertisement

Featured Speakers

  • Irena Melnikova, Ph.D., partner, Pfizer Ventures
  • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
  • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Hospitals struggle to profit from CAR
Next article： BioMarin wins approval for gene therapy to treat hemophilia A